Prevalence, demographic factors, co-morbidities, and treatment types associated with acanthosis nigricans in a large cross-section of 900+ transmasculine patients: Data from a single academic center 2016–2023
Table 5
Among transmasculine patients with acanthosis nigricans (n = 43), AN appeared before, concurrently, or after diagnosis of co-morbidities. Some patients had multiple of these comorbidities and thus are represented in multiple columns.